SEC Form 4 · accession 0001817449-26-000009
Electra Therapeutics, Inc. · ETRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nancy Stagliano
Director
Period of report
Sep 21, 2026
Accepted (ET)
Sep 21, 2026 · 6:19 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002088082
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 21, 2026 | C | 255,635 | — | A | 255,635 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Convertible Preferred StockF1 | — | Sep 21, 2026 | C | 255,635 | D | — | — | Common Stock | 255,635 | 0 | D |
Explanation of responses
- F1Each share of Series A Convertible Preferred Stock (the "Preferred Stock") converted automatically into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date.